Hikma Pharmaceuticals PLC the fast growing multinational pharmaceutical group, announces that it has, through its wholly owned US subsidiary West-Ward Pharmaceuticals, signed a development and licensing agreement with Vectura for its generic salmeterol product (VR730).
GE Healthcare’s Life Sciences business and Valneva SE, a fully integrated vaccine biotech company, are sharing the results of a successful collaboration to optimize virus productivity in Valneva’s EB66® cell-line, a proprietary technology for the production of a wide variety of vaccines, including human and animal health vaccines.
Law enforcement agents, narcotics officers and customs personnel can now quickly and safely detect street drug W-18 and other lethal drugs with the newest library update for the Thermo Scientific TruNarc handheld narcotics analyzer. W-18 is a new designer drug considered to be significantly more potent than morphine and fentanyl.
Breckenridge Pharmaceutical, Inc. announced the immediate launch of Methylergonovine Maleate Injection, USP 0.2mg/mL. This product is an AP rated generic to Methergine®, a product owned by Edison Therapeutics, LLC. and is a semi-synthetic ergot alkaloid used for the prevention and control of postpartum hemorrhage.
Daiichi Sankyo Company, Limited announced that it has entered into a strategic collaboration with AgonOx, Inc., a privately held biotechnology company developing a pipeline of novel immunotherapy drugs targeting key regulators of the immune response to cancer, to develop an undisclosed immuno-oncology target.